Pag-aaral pangklinika para sa Lupus sa Pennsylvania
14 pag-aaral para sa Lupus ang naghahanap ng mga kalahok sa mga site sa Pennsylvania.
Mga Lungsod sa Pennsylvania
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50365, Pittsburgh
Nagre-recruitPhase 3
Edad 16 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06617325Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Temple University, Philadelphia
Nagre-recruitPhase 2
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT05268289A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- Altoona Arthritis & Osteoporosis Center - Altoona Center for Clinical Research, Duncansville
Nagre-recruitPhase 2
Edad 18 hanggang 74 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07409181Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- University Of Pittsburgh, Pittsburgh
Nagre-recruitPhase 3
Edad 12 hanggang 100 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06133972An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- Research Site, Philadelphia
Nagre-recruitPhase 3
Edad 5 hanggang 17 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT05835310A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Clinical Research Philadelphia, Philadelphia
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07438496CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
- Children's Hospital of Philadelphia, Philadelphia
Nagre-recruitPhase 1/2
Edad 10 hanggang 29 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06839976Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UPMC Hillman Cancer Center, Pittsburgh
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT03816345A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
- Fox Chase Cancer Center- Temple BMT, Philadelphia
Nagre-recruitPhase 2
Edad 16 hanggang 70 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07328581A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Local Institution - 0075, Philadelphia
- Local Institution - 0052, Philadelphia
Nagre-recruitObservasyonal na pag-aaral
Edad 16 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07175285RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- Children's Hospital of Philadelphia, Philadelphia
Nagre-recruitPhase 1/2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Ago 26, 2026 · NCT06121297Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
- Penn State MS Hershey Medical Center, Hershey
Nagre-recruitPhase 3
Edad 55 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT05799378A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Jefferson Einstein Hospital Philadelphia, Philadelphia
Nagre-recruitPhase 1
Edad 12 hanggang 70 · Lahat ng kasarian · Na-update May 22, 2026 · NCT06308978Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases
- Children's Hospital of Philadelphia, Philadelphia
Nagre-recruitPhase 2
Edad 8 hanggang 25 · Lahat ng kasarian · Na-update Okt 14, 2025 · NCT05029336Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.